Primary outcome measure for possible randomised controlled trial by assessment time and study group
| Quality of life | Study group | Baseline Mean (SD) Median (IQR) | 6 week Mean (SD) Median (IQR) | 12 week Mean (SD) Median (IQR) | 24 week Mean (SD) Median (IQR) |
|---|---|---|---|---|---|
| FACT-G total score22 | Control | 52 (9.1) 53 (11.0) | 51 (11.2) 56 (17.5) | 50 (7.9) 52 (13.0) | 48 (12.7) 54 (20.0) |
| Intervention | 57 (5.2) 58 (4.0) | 56 (6.3) 57 (7.25) | 55 (5.5) 56 (4.0) | 57 (6.9) 56 (10.5) | |
| Cohen's d effect size (95% CI) | 0.67 (0.04 to 1.28) | 0.55 (−0.19 to 1.26) | 0.73 (−0.07 to 1.49) | 0.79 (−0.09 to 1.62) | |
| Physical well-being subscale | Control | 22 (5.8) 24 (7.0) | 21 (5.7) 21 (10.5) | 22 (5.7) 25 (11.0) | 23 (4.5) 24 (7.5) |
| Intervention | 23 (4.7) 26 (6.0) | 25 (2.4) 26 (4) | 25 (3.3) 26 (6.0) | 23 (4.7) 25 (4.7) | |
| Cohen's d effect size (95% CI) | 0.19 (−0.42 to 0.79) | 0.91 (0.14 to 1.64) | 0.64 (−0.15 to 1.39) | 0.00 (−0.82 to 0.82) | |
| Social and family well-being subscale | Control | 20 (6.1) 21 (11) | 19 (7.0) 21 (10.75) | 19 (6.2) 19 (10.0) | 18 (7.3) 20 (12.5) |
| Intervention | 22 (3.6) 23 (6.0) | 22 (3.9) 23 (6.0) | 22 (4.0) 23 (4.0) | 22 (5.5) 23 (8.0) | |
| Cohen's d effect size (95% CI) | 0.40 (−0.22 to 1.00) | 0.53 (−0.21 to 1.24) | 0.57 (−0.22 to 1.32) | 0.61 (−0.26 to 1.43) | |
| Emotional well-being subscale | Control | 17 (5.2) 16 (8.0) | 18 (4.4) 19 (5.3) | 19 (3.8) 19 (6.0) | 20 (3.3) 20 (6.5) |
| Intervention | 17 (5.5) 19 (7.0) | 20 (3.6) 20 (4.0) | 20 (3.7) 21 (6.0) | 18 (3.8) 18 (6.2) | |
| Cohen's d effect size (95% CI) | 0.00 (−0.60 to 0.60) | 0.50 (−0.24 to 1.21) | 0.27 (−0.50 to 1.02) | −0.57 (−1.39 to 0.29) | |
| Functional well-being subscale | Control | 18 (5.0) 19 (9.0) | 17 (6.6) 17.5 (10.3) | 19 (6.5) 19 (11.0) | 21 (7.6) 23 (14.5) |
| Intervention | 21 (6.5) 23 (13.0) | 23 (5.6) 26 (8.0) | 23 (4.7) 23 (7.0) | 23 (5.3) 25 (8.0) | |
| Cohen's d effect size (95% CI) | 0.52 (−0.11 to 1.12) | 0.98 (0.20 to 1.71) | 0.70 (−0.10 to 1.46) | 0.30 (−0.54 to 1.12) |
FACT, Functional Assessment of Cancer Therapy-General.